Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Harrow Health Inc (HROW)  
$10.43 0.24 (2.36%) as of 4:30 Wed 5/1


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 25,750,000
Market Cap: 268.57(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $8.1 - $28.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 14.6
Insider 6 Months    : 15.4
Insider 3/6 Months : 30.2
Guru Rank Number :  140
Guru Rank Value     : 7.2
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Harrow Health engages in the development, production and sale of medications. Co. owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical businesses. Through its subsidiaries, Visionology, Inc., which provides an online eye health platform; Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 179,000 211,500 257,300 699,568
Total Buy Value $1,948,031 $2,209,591 $2,938,957 $7,583,356
Total People Bought 2 2 3 3
Total Buy Transactions 7 9 13 15
Total Shares Sold 0 0 0 40,000
Total Sell Value $0 $0 $0 $504,800
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 181
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Opaleye Management Inc. 10% Owner   –       –       •   2024-04-25 4 B $9.97 $199,400 I/I 20,000 3,815,000 1.5 2%     
   Opaleye Management Inc. 10% Owner   –       –       •   2024-04-24 4 B $10.15 $84,093 I/I 8,285 3,795,000 1.5 -1%     
   Opaleye Management Inc. 10% Owner   –       –       •   2024-04-23 4 B $10.29 $120,547 I/I 11,715 3,786,715 1.5 -1%     
   Opaleye Management Inc. 10% Owner   –       –       •   2024-04-19 4 B $10.56 $310,391 I/I 29,400 3,775,000 1.5 -2%     
   Opaleye Management Inc. 10% Owner   –       –       •   2024-03-28 4 B $12.82 $641,000 I/I 50,000 3,745,600 1.5 -23%     
   Baum Mark L CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-22 4 B $11.59 $104,310 D/D 9,000 2,137,525 2.81 -11%     
   Opaleye Management Inc. 10% Owner   –       –       •   2024-03-20 4 B $9.65 $488,290 I/I 50,600 3,695,600 1.5 -3%     
   Saharek John P. CEO of ImprimisRx   •       –      –    2024-03-01 4 OE $8.75 $43,750 D/D 5,000 254,803     -
   Baum Mark L CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-20 4 OE $10.67 $638,450 D/D 59,836 2,128,525     -
   Baum Mark L CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-20 4 OE $10.67 $1,600,500 D/D 150,000 2,188,361     -
   Boll Andrew CHIEF FINANCIAL OFFICER   •       –      –    2024-02-20 4 OE $10.67 $197,182 D/D 18,480 568,089     -
   Boll Andrew CHIEF FINANCIAL OFFICER   •       –      –    2024-02-20 4 OE $10.67 $480,150 D/D 45,000 586,569     -
   Saharek John P. CEO of ImprimisRx   •       –      –    2024-02-20 4 OE $10.67 $134,613 D/D 12,616 249,803     -
   Saharek John P. CEO of ImprimisRx   •       –      –    2024-02-20 4 OE $10.67 $320,100 D/D 30,000 262,419     -
   Boll Andrew CHIEF FINANCIAL OFFICER   •       –      –    2024-02-07 4 OE $7.71 $57,054 D/D 7,400 541,569     -
   Baum Mark L CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-07 4 OE $7.71 $118,734 D/D 15,400 2,038,361     -
   Baum Mark L Chief Executive Officer   •       •      –    2023-11-16 4 B $8.11 $60,825 D/D 7,500 2,022,961 2.81 54%     
   Opaleye Management Inc. 10% Owner   –       –       •   2023-11-15 4 B $8.03 $200,735 I/I 25,000 3,645,000 1.5 57%     
   Saharek John P. Chief Commercial Officer   •       –      –    2023-11-10 4 D $12.83 $125,452 D/D (9,778) 232,419     -
   Saharek John P. Chief Commercial Officer   •       –      –    2023-11-10 4 OE $0.00 $0 D/D 20,000 242,197     -
   Opaleye Management Inc. 10% Owner   –       –       •   2023-09-20 4 B $14.49 $86,710 I/I 5,983 3,620,000 1.5 -32%     
   Opaleye Management Inc. 10% Owner   –       –       •   2023-09-19 4 B $14.65 $205,366 I/I 14,017 3,614,017 1.5 -32%     
   Baum Mark L Chief Executive Officer   •       •      –    2023-08-14 4 B $17.05 $98,890 D/D 5,800 2,015,461 2.81 -42%     
   Makary Martin A. Director   –       •      –    2023-08-14 4 B $16.92 $338,400 D/D 20,000 45,000 2.39 -42%     
   Boll Andrew Chief Financial Officer   •       –      –    2023-07-18 4 D $18.23 $2,485,661 D/D (136,350) 534,169     -
  181 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us